We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA and BIO Say European Proposals Hurt Patent Rights
PhRMA and BIO Say European Proposals Hurt Patent Rights
PhRMA and BIO called on U.S. trade officials to add the European Union to a list of countries that do not adequately protect intellectual property following the release of two EU proposals the groups say could hurt patent rights.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor